Corus® CADCorus CAD is the only blood test that can quickly
and safely identify symptomatic patients unlikely to
have obstructive coronary artery disease (CAD).
and safely identify symptomatic patients unlikely to
have obstructive coronary artery disease (CAD).
Latest News COMPASS trial results presented at AHA Scientific Sessions 2011. Corus CAD outperformed MPI in diagnostic accuracy and negative predictive value in the assessment of obstructive CAD.
PREDICT one-year data now published. Results provide evidence for the clinical utility of Corus CAD for safely excluding obstructive CAD as the cause of patient’s symptoms.
PREDICT one-year data now published. Results provide evidence for the clinical utility of Corus CAD for safely excluding obstructive CAD as the cause of patient’s symptoms.
Women and Heart Disease
Learn more about women and heart disease, and assessment of obstructive coronary artery disease
in women.
For Clinicians >
For Patients >
Learn more about women and heart disease, and assessment of obstructive coronary artery disease
in women.
For Clinicians >
For Patients >
